Overexpression of p53 protein in basal cell carcinomas of human skin. 1992

C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
Department of Pathology, New York Hospital-Cornell Medical Center, New York 10021.

Basal cell carcinoma (BCC) of the skin is the most common human cancer, but its molecular-genetic pathogenesis is unclear. In many other types of cancer, mutations of the tumor-suppressor gene p53 occur frequently and may lead to overexpression of a long-lived mutant form of p53 protein. In this study, overexpression of p53 protein was detected immunohistochemically in 30 (83%) of 36 specimens of BCC of the head and neck. The same regions of tumor typically were reactive both with a monoclonal antibody (PAb240) specific for the mutant protein and with one (PAb1801) directed against an epitope common to both wild-type and mutant p53 protein. Keratinocytes of chronically sun-exposed epidermis adjacent to BCCs also focally overexpressed p53 protein in the majority of cases, whereas those of sun-protected buttock skin did not. Mutation of p53 may form an important part of the pathogenetic sequence in a majority of cases of BCC.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D002280 Carcinoma, Basal Cell A malignant skin neoplasm that seldom metastasizes but has potentialities for local invasion and destruction. Clinically it is divided into types: nodular, cicatricial, morphaic, and erythematoid (pagetoid). They develop on hair-bearing skin, most commonly on sun-exposed areas. Approximately 85% are found on the head and neck area and the remaining 15% on the trunk and limbs. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1471) Carcinoma, Basal Cell, Pigmented,Epithelioma, Basal Cell,Rodent Ulcer,Ulcer, Rodent,Basal Cell Carcinoma,Basal Cell Carcinomas,Basal Cell Epithelioma,Basal Cell Epitheliomas,Carcinomas, Basal Cell,Epitheliomas, Basal Cell,Rodent Ulcers,Ulcers, Rodent
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000369 Aged, 80 and over Persons 80 years of age and older. Oldest Old

Related Publications

C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
December 1992, Histopathology,
C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
July 1992, Cancer research,
C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
April 1995, Journal of Korean medical science,
C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
April 1990, The Journal of investigative dermatology,
C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
January 2003, Clinical cancer research : an official journal of the American Association for Cancer Research,
C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
December 2006, Oncogene,
C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
March 1996, Biochemical and biophysical research communications,
C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
September 1994, Cancer research,
C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
February 1993, Cancer research,
C R Shea, and N S McNutt, and M Volkenandt, and J Lugo, and P G Prioleau, and A P Albino
February 1995, Cancer research,
Copied contents to your clipboard!